/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Umlaut.bio GmbH

Umlaut.bio GmbH

Heidelberg, Germany

Umlaut.bio GmbH is a biotech company developing therapeutic molecules to modify tRNA and target cancers and inflammatory diseases

Healthcare & Biotech

Umlaut.bio GmbH, based in Heidelberg, Germany, has 2 investors on file, among them High-Tech Gründerfonds and LBBW Venture Capital. Its latest round on record is Seed, 20 Feb 2026. Its site was last checked 13 Nov 2026: site answers.

umlaut.bio

Funding

1 round on record
Latest roundSeed20 Feb 2026
Since that round9 monthsno later round on record
Investors in its rounds32 with a VCinfo profile
Feb 2026SeedLed by BaseLaunch, with High-Tech Gründerfonds, LBBW Venture Capital

Round sizes and total raised are on Fundup AI, our sister product for funding data.

Investors

2 investors on file
InvestorEvidenceType
High-Tech GründerfondsPortfolio pageVenture capital
LBBW Venture CapitalPage + roundCorporate VC

More from High-Tech Gründerfonds

114 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (21%), AI & Machine Learning (20%), Industrial & Manufacturing (18%).

AltavoAltavo is a medical device startup that works to help voiceless people…Avelios MedicalAvelios Medical develops a clinical information system for hospitals u…BTRYBTRY develops and produces solid-state batteries for various applicati…BiograilBiograil is a pre-clinical stage pharmaceutical company unlocking the …CancilicoCancilico develops AI-assisted bone marrow morphology technology for d…

See High-Tech Gründerfonds' full profile · Who invests alongside it

More from LBBW Venture Capital

23 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (32%), AI & Machine Learning (23%), Industrial & Manufacturing (13%).

Bluu BioscienceBLUU develops marine ingredients through controlled biomanufacturingExcivaExciva is developing a groundbreaking therapy that effectively and saf…Oska HealthOska Health provides personal health and nutrition counseling services…Acousia TherapeuticsThe company develops novel compounds to enhance and preserve natural h…ActiTrexx Life ScienceActiTrexx is developing novel therapies based on activated regulatory …

See LBBW Venture Capital's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Umlaut.bio GmbH and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when High-Tech Gründerfonds adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/umlaut.bio/investors

# also
GET /v1/companies/umlaut.bio
GET /v1/companies/umlaut.bio/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing